U.S. Wireless Telecom Stock News

Medtronic has signed a three-year deal with Minze Health to commercialize the Minze Diary Pod across Europe, the Middle East and Africa. This move strengthens Medtronic’s digital health offerings for patients using its InterStim system for bladder control. See our latest analysis for Medtronic. Following the Minze Health partnership and a recent executive transition, Medtronic’s share price momentum has been building, with a 19.4% year-to-date share price return and a 12.5% total shareholder...

Abaxx Technologies Inc. recently announced the upcoming launch of the Enwex German Wind (GWM) Futures, the first wind futures contract based on Enwex indices in Germany, with trading set to begin on November 14, 2025. This contract introduces a new tool for the renewable energy market by enabling participants to hedge weather-related volume risk in German wind power generation through a standardized, financially-settled futures product. We'll explore how the introduction of wind futures...

Kennametal Inc. recently raised its full-year fiscal 2026 sales guidance to between US$2.1 billion and US$2.17 billion, following first-quarter results that saw sales rise to US$497.97 million and net income increase to US$23.3 million compared to the previous year. This upbeat outlook, paired with recent share repurchases and a quarterly dividend affirmation, highlights management’s focus on returning capital to shareholders while benefiting from share gains and modest improvements in its...

Veeva Systems (VEEV) has been gaining some attention lately following a steady climb in recent weeks. The cloud software provider for the life sciences industry is up roughly 8% over the past 3 months, leaving investors weighing what could come next for the stock. See our latest analysis for Veeva Systems. Momentum continues to build for Veeva Systems, with a 41% year-to-date share price return and a 27% total shareholder return over the past year. The latest moves suggest investors are...

enGene Holdings recently reported additional preliminary efficacy data from its pivotal Phase 2 LEGEND trial for detalimogene voraplasmid in patients with high-risk, BCG-unresponsive non-muscle invasive bladder cancer, along with a protocol amendment changing the primary clinical endpoint after discussions with the FDA. This update reveals that earlier patients in the study experienced a lower 12-month complete response rate compared to FDA-approved therapies, leading to significant...

AAR (AIR) shares have shown steady traction lately, gaining over 3% over the past month and returning 22% to investors over the past year. Investors are watching closely to see if this momentum continues. See our latest analysis for AAR. With a recent 2.9% one-month share price return and an impressive 22.4% total shareholder return over the past year, AAR looks to be maintaining positive momentum. This reflects renewed optimism about its long-term growth potential despite a slight dip in the...

JD.com (NasdaqGS:JD) is under the spotlight this week as several analyst downgrades, particularly Morgan Stanley’s, have raised fresh concerns about the company’s slowing revenue growth and continued pressure on profit margins. See our latest analysis for JD.com. Despite JD.com's record-breaking performance during Singles Day and ongoing expansion into new business verticals, recent selloffs show that investors remain wary. The share price is down 8.7% year-to-date, and its one-year total...

PPL (PPL) recently released its third quarter results, revealing strong year-over-year growth in both revenue and net income. The company also reaffirmed its 2025 earnings guidance and reiterated expected long-term EPS and dividend growth. See our latest analysis for PPL. PPL’s upbeat earnings report and renewed guidance have given investors more confidence, helping to fuel its steady momentum. The company has delivered a 14.6% year-to-date share price return and a total shareholder return of...

Marvell Technology recently attracted attention following industry concern over a data center company's delayed financials, yet still saw analysts revise their earnings expectations upward in anticipation of its December 2, 2025, earnings report. Amid sector-wide uncertainty, investor optimism about Marvell's projected year-over-year earnings growth and analyst estimate increases has kept the focus on its business operations and profit potential. We'll look at how elevated analyst optimism...

SoFi Technologies (SOFI) just made waves by becoming the first nationally chartered bank to roll out consumer crypto trading. This strategic step positions the company at the forefront of digital financial services and draws the spotlight back to its expanding fintech platform. See our latest analysis for SoFi Technologies. With 2025 bringing SoFi’s crypto launch, record member growth, and a new focus on financial empowerment, momentum has been building fast. This is reflected in the 127.95%...

Ameresco (AMRC) just reported higher sales and net income for both its third quarter and year-to-date results, compared to last year. The company also maintained its full-year revenue outlook, highlighting its ongoing growth story. See our latest analysis for Ameresco. Ameresco has stayed in the news lately, breaking ground on new clean energy projects, presenting at key industry conferences, and reiterating its earnings guidance for 2025. Despite a sharp 19% dip in its 30-day share price...

Sandisk (SNDK) kicked off this week in the spotlight after releasing its first quarter earnings, showing a jump in sales but a drop in net income compared to last year. Investors are also weighing the company’s fresh revenue guidance for the upcoming quarter. See our latest analysis for Sandisk. After this strong earnings release and updated revenue outlook, Sandisk's stock has clearly grabbed the market’s attention, notching a remarkable 30-day share price return of 110%, and an even more...

Recursion Pharmaceuticals (RXRX) just announced a leadership shift, with Najat Khan set to become CEO starting January 2026. The company also reported weaker quarterly earnings with lower revenue and deeper losses than last year. These developments are getting close investor attention. See our latest analysis for Recursion Pharmaceuticals. It has been a tough stretch for Recursion Pharmaceuticals, as the recent CEO transition and disappointing quarterly results have contributed to fading...

V2X (VVX) has caught investor attention this week after posting better quarterly earnings, raising its full-year revenue forecast, and completing a buyback program. All of these factors point to growing operational confidence. See our latest analysis for V2X. V2X’s improved earnings, higher revenue outlook, and buyback wrap-up have fueled optimism, but momentum has cooled lately. The stock’s 16.6% share price return year-to-date is impressive, although its one-year total shareholder return...

Extreme Networks (EXTR) released updated revenue targets and margin guidance for fiscal 2026 during its recent Investor Day presentation, confirming expectations for steady growth. The company also reaffirmed its outlook for the current quarter. See our latest analysis for Extreme Networks. Extreme Networks’ share price has grabbed attention lately, surging more than 4% in a single day after its updated guidance. The stock has experienced a volatile month, with a 9% year-to-date gain offset...

Bristow Group (NYSE:VTOL) shares moved after the company released its third-quarter results. Earnings per share came in ahead of expectations, and adjusted EBITDA climbed over 10% from the previous quarter. See our latest analysis for Bristow Group. Bristow Group's upbeat earnings and increased guidance have put a spotlight on the stock, though investor enthusiasm cooled recently, with a 2.5% decline in the 7-day share price. Looking beyond the short-term pullback, the company still boasts a...

Progyny (PGNY) shares have been moving steadily in recent weeks, drawing interest from investors following a string of positive returns. Over the past month, the stock has climbed 18%, reflecting renewed attention on the fertility benefits provider. See our latest analysis for Progyny. Progyny’s recent momentum has certainly caught investors’ attention, with a 27% 7-day share price return building on steady gains. The stock’s 73% total shareholder return over the past year shows how sentiment...

BankUnited, Inc. recently named James G. Mackey as its new chief financial officer, effective November 10, 2025, with former CFO Leslie N. Lunak moving into an advisory role through January 2026. This leadership shift brings fresh financial oversight at a time when the bank has reported a Non-GAAP EPS of US$0.95 for the recent quarter, exceeding expectations. We'll examine how this executive transition may influence BankUnited's investment narrative, particularly as new financial leadership...

Curious if Ralliant is still a hidden gem, or if recent moves have pushed it into overvalued territory? Let’s break down the big questions around whether it deserves a spot on your watchlist. Ralliant’s stock has caught attention by rising 7.6% over the past week and jumping an impressive 14.2% in the last month. This suggests growing investor interest or shifting risk perceptions. In the backdrop, major partnership announcements and industry expansion news have kept Ralliant in the...

VinFast Auto (NasdaqGS:VFS) grabbed attention after announcing it delivered more than 20,000 electric vehicles in Vietnam in October 2025. This achievement makes it the first domestic automaker to reach this milestone. See our latest analysis for VinFast Auto. This milestone isn’t happening in a vacuum. Despite headline-making delivery growth and plans to launch new EV models this year, VinFast Auto’s share price has slipped 17% year-to-date and its total shareholder return over the past year...

Ellington Financial (EFC) just declared a new monthly dividend of $0.13 per share, following a third quarter marked by higher revenue and improved profits. The company’s robust loan growth and earnings outlook remain in focus for investors. See our latest analysis for Ellington Financial. Following the upbeat earnings and a fresh dividend, Ellington Financial’s momentum has been quietly building. While the share price is up 13% year-to-date, what really stands out is the 27% total shareholder...

Pinnacle West Capital (PNW) shared its third quarter results and simultaneously raised earnings guidance for 2025. The company pointed to higher customer and sales growth supported by favorable weather trends, despite increased operations and maintenance costs. See our latest analysis for Pinnacle West Capital. After raising its earnings guidance and reaffirming upbeat sales growth targets, Pinnacle West Capital’s stock is starting to reflect a bit more investor optimism, with a year-to-date...

Penguin Solutions (PENG) has announced its participation at the upcoming Supercomputing 25 conference in St. Louis. The company plans to demonstrate scalable AI infrastructure solutions and highlight its collaboration with SK Telecom on a significant South Korean AI initiative. See our latest analysis for Penguin Solutions. PENG’s latest moves in high-performance computing come as the company’s momentum remains solid, with a 21.3% total shareholder return over the past year and a healthy 41%...

ImmunityBio (IBRX) drew investor attention after releasing its third quarter earnings. The report revealed revenue climbing substantially to $32 million and a narrowed net loss compared to the same period last year. The improved results have prompted fresh discussion around the company’s progress. See our latest analysis for ImmunityBio. Despite the standout jump in revenue and improving losses, ImmunityBio’s share price return has struggled over the past year. The 1-year total shareholder...